Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
eko.ai is a private digital health company focused on applying machine learning to echocardiography and related cardiac data to improve heart disease prediction and workflow automation. The company develops software tools intended to help research teams and health systems classify echocardiography data, build machine-learning-ready datasets, and deploy models for segmentation, validation, and disease prediction. Based on available public information, eko.ai appears to operate as an AI diagnostics and cardiovascular analytics company rather than a therapeutics developer. It is healthcare-related, but it does not appear to have a traditional drug pipeline or clinical-stage therapeutic assets. The company is best understood as a cardiovascular AI platform business serving research and diagnostic use cases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on eko.ai.